338
Participants
Start Date
January 31, 2003
Primary Completion Date
December 31, 2008
Study Completion Date
April 30, 2009
Epirubicin
100 mg/m² every three weeks (4 cycles) or every two weeks (6 cycles)
Jules Bordet Institute, Brussels
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
Centre Paul Strauss
OTHER
Centre Hospitalier du Luxembourg
OTHER
Clinique Louis Cathy - Baudour - Belgium
UNKNOWN
HIS - Site Etterbeek - Ixelles - Belgium
UNKNOWN
Clinique Saint Pierre Ottignies
OTHER
Clinique Ste Elisabeth - Namur - Belgium
UNKNOWN
University Hospital of Crete
OTHER
Feculdade de Medicina da Universidade de Sao Paulo - Brasil
OTHER
Jules Bordet Institute
OTHER